A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis

Psychological Medicine

Volumn 45, Issue 1, 2015, Pages 205-216

  Gutierrez Galve L ^a,b,c   Chu, E M ^a   Leeson, V C ^b   Price, G ^a   Barnes, T R E ^b   Joyce, E M ^a   Ron, M A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Cognitive impairment; cortical area; cortical thickness; first episode psychosis; follow up; magnetic resonance imaging; surface based morphometry

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; CASE CONTROL STUDY; CEREBELLUM CORTEX; COGNITION DISORDERS; COMPLICATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PSYCHOTIC DISORDERS; STATISTICAL MODEL; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CEREBELLAR CORTEX; COGNITION DISORDERS; FEMALE; HUMANS; LINEAR MODELS; LONDON; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84925497890     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714001433     Document Type: Article

References (67)

1. Andreasen N (1983). The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa: Iowa City, IA.
2. Andreasen N (1984). The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa: Iowa City, IA.
3. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC (2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biological Psychiatry 70, 672-679.
4. Annett M (1970). A classification of hand preference by association analysis. British Journal of Psychology 61, 303-321.
5. Arango C, Moreno C, Martinez S, Parellada M, Desco M, Moreno D, Fraguas D, Gogtay N, James A, Rapoport J (2008). Longitudinal brain changes in early-onset psychosis. Schizophrenia Bulletin 34, 341-353.
6. Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Parellada M, Moreno D, Bargallo N, Desco M (2012). Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry 69, 16-26.
7. Asami T, Bouix S, Whitford TJ, Shenton ME, Salisbury DF, McCarley RW (2012). Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage 59, 986-996.
8. Boksa P (2012). Abnormal synaptic pruning in schizophrenia: urban myth or reality? Journal of Psychiatry and Neuroscience 37, 75-77.
9. Brans RG, van Haren NE, van Baal GC, Schnack HG, Kahn RS, Hulshoff Pol HE (2008). Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Archives of General Psychiatry 65, 1259-1268.
10. Breslow NE, Clayton DG (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association 88, 9-25.
11. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ (2004). A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 23, 724-738.
12. Cobia DJ, Smith MJ, Wang L, Csernansky JG (2012). Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophrenia Research 139, 1-6.
13. Dale AM, Fischl B, Sereno MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9, 179-194.
14. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968-980.
15. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16, 57-67.
16. Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW (2007). Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130, 1159-1166.
17. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008). The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. American Journal of Psychiatry 165, 1015-1023.
18. Fischl B, Dale AM (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences USA 97, 11050-11055.
19. Fischl B, Sereno MI, Dale AM (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 9, 195-207.
20. Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S (2013). Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neuroscience and Biobehavioral Reviews 37, 1680-1691.
21. Genovese CR, Lazar NA, Nichols T (2002). Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15, 870-878.
22. Giedd JN, Schmitt JE, Neale MC (2007). Structural brain magnetic resonance imaging of pediatric twins. Human Brain Mapping 28, 474-481.
23. Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, Macewan GW, Lang DJ (2013). Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naive first-episode psychosis patients. Schizophrenia Research 149, 149-155.
24. Gutiérrez-Galve L, Flugel D, Thompson PJ, Koepp MJ, Symms MR, Ron MA, Foong J (2012). Cortical abnormalities and their cognitive correlates in patients with temporal lobe epilepsy and interictal psychosis. Epilepsia 53, 1077-1087.
25. Gutiérrez-Galve L, Wheeler-Kingshott CA, Altmann DR, Price G, Chu EM, Leeson VC, Lobo A, Barker GJ, Barnes TR, Joyce EM, Ron MA (2010). Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biological Psychiatry 68, 51-60.
26. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
27. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128-137.
28. Huddy VC, Hodgson TL, Kapasi M, Mutsatsa SH, Harrison I, Barnes TR, Joyce EM (2007). Gaze strategies during planning in first-episode psychosis. Journal of Abnormal Psychology 116, 589-598.
29. Hulshoff Pol HE, Kahn RS (2008). What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophrenia Bulletin 34, 354-366.
30. Ivleva EI, Bidesi AS, Keshavan MS, Pearlson GD, Meda SA, Dodig D, Moates AF, Lu H, Francis AN, Tandon N, Schretlen DJ, Sweeney JA, Clementz BA, Tamminga CA (2013). Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). American Journal of Psychiatry 170, 1285-1296.
31. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, Carr V, Morgan V, Korten A, Harvey C (2000). Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry 34, 221-236.
32. Joyce EM, Hutton SB, Mutsatsa SH, Barnes TR (2005). Cognitive heterogeneity in first-episode schizophrenia. British Journal of Psychiatry 187, 516-522.
33. Khandaker GM, Barnett JH, White IR, Jones PB (2011). A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132, 220-227.
34. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA (2007). Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32, 1216-1223.
35. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Goff D, West WC, Williams SC, van der Kouwe AJ, Salat DH, Dale AM, Fischl B (2003). Regionally localized thinning of the cerebral cortex in schizophrenia. Archives General of Psychiatry 60, 878-888.
36. Leeson VC, Sharma P, Harrison M, Ron MA, Barnes TR, Joyce EM (2011). IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study. Schizophrenia Bulletin 37, 768-777.
37. Lezak MD (1995). Neuropsychological Assessment. Oxford University Press: New York, NY.
38. Martin-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine 40, 383-398.
39. Minatogawa-Chang TM, Schaufelberger MS, Ayres AM, Duran FL, Gutt EK, Murray RM, Rushe TM, McGuire PK, Menezes PR, Scazufca M, Busatto GF (2009). Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis. Schizophrenia Research 113, 200-209.
40. Moncrieff J, Leo J (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine 40, 1409-1422.
41. Murray GK, Corlett PR, Fletcher PC (2010). The neural underpinnings of associative learning in health and psychosis: how can performance be preserved when brain responses are abnormal? Schizophrenia Bulletin 36, 465-471.
42. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal (Clinical Research Edition) 295, 681-682.
43. Narr KL, Bilder RM, Toga AW, Woods RP, Rex DE, Szeszko PR, Robinson D, Sevy S, Gunduz-Bruce H, Wang YP, De Luca H, Thompson PM (2005). Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cerebral Cortex 15, 708-719.
44. Nelson H, Willson J (1991). The Revised National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor.
45. Owens SF, Picchioni MM, Ettinger U, McDonald C, Walshe M, Schmechtig A, Murray RM, Rijsdijk F, Toulopoulou T (2012). Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain 135, 2231-2244.
46. Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson K, Lyons MJ, Grant MD, Franz CE, Xian H, Tsuang M, Fischl B, Seidman L, Dale A, Kremen WS (2009). Distinct genetic influences on cortical surface area and cortical thickness. Cerebral Cortex 19, 2728-2735.
47. Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA (2000). Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophrenia Research 44, 1-10.
48. Rais M, Cahn W, Van Haren N, Schnack H, Caspers E, Hulshoff Pol H, Kahn R (2008). Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. American Journal of Psychiatry 165, 490-496.
49. Reilly JL, Sweeney JA (2014). Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery. Schizophrenia Bulletin 40, 516-522.
50. Reuter M, Fischl B (2011). Avoiding asymmetry-induced bias in longitudinal image processing. NeuroImage 57, 19-21.
51. Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012). Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage 61, 1402-1418.
52. Roiz-Santianez R, Tordesillas-Gutierrez D, Ortiz-Garcia de la Foz V, Ayesa-Arriola R, Gutierrez A, Tabares-Seisdedos R, Vazquez-Barquero JL, Crespo-Facorro B (2012). Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Schizophrenia Research 141, 22-28.
53. Sahakian BJ, Owen AM (1992). Computerized assessment in neuropsychiatry using CANTAB: discussion paper. Journal of the Royal Society of Medicine 85, 399-402.
54. Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Gaser C, Nenadic I, Reichenbach JR, Sauer H, Schlosser RG (2010). Reduced cortical thickness in first episode schizophrenia. Schizophrenia Research 116, 204-209.
55. Selemon LD (2001). Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophrenia Bulletin 27, 349-377.
56. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, van Erp TG, Thompson PM, Toga AW, Smith DJ, Cannon TD, Pantelis C (2009). Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Molecular Psychiatry 14, 976-986.
57. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL (2001). Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences USA 98, 11650-11655.
58. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269-275.
59. van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS (2012). The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology 26, 8-14.
60. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, Rais M, Kahn RS (2008). Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biological Psychiatry 63, 106-113.
61. van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2011). Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry 68, 871-880.
62. Vernon AC, Natesan S, Modo M, Kapur S (2011). Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biological Psychiatry 69, 936-944.
63. Vidal CN, Rapoport JL, Hayashi KM, Geaga JA, Sui Y, McLemore LE, Alaghband Y, Giedd JN, Gochman P, Blumenthal J, Gogtay N, Nicolson R, Toga AW, Thompson PM (2006). Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Archives of General Psychiatry 63, 25-34.
64. Voets NL, Hough MG, Douaud G, Matthews PM, James A, Winmill L, Webster P, Smith S (2008). Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. NeuroImage 43, 665-675.
65. Wechsler D (1997). Wechsler Adult Intelligence Scale - 3rd Edition (WAIS-III). The Psychological Corporation: San Antonio, TX.
66. Wisco JJ, Kuperberg G, Manoach D, Quinn BT, Busa E, Fischl B, Heckers S, Sorensen AG (2007). Abnormal cortical folding patterns within Broca's area in schizophrenia: evidence from structural MRI. Schizophrenia Research 94, 317-327.
67. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.